# Enhancement of Stroke Rehabilitation With Levodopa

Study · id `cardio:ct-nct03735901` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03735901](<https://clinicaltrials.gov/study/NCT03735901>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03735901

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 610 participants.

## Technical summary

Registry record NCT03735901. Randomized; quadruple masking; primary purpose treatment. Start 2019-06-14 (actual); primary completion 2024-08-27 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 610 participants (enrolled count; ClinicalTrials.gov record NCT03735901, source copy `cardio:ctgov-nct03735901-2024-10-15`, retrieved 2026-10-26)
- Started: 2019-06-14 (actual) (ClinicalTrials.gov record NCT03735901, source copy `cardio:ctgov-nct03735901-2024-10-15`, retrieved 2026-10-26)
- Primary completion: 2024-08-27 (actual) (ClinicalTrials.gov record NCT03735901, source copy `cardio:ctgov-nct03735901-2024-10-15`, retrieved 2026-10-26)
- Completion: 2029-06-30 (anticipated) (ClinicalTrials.gov record NCT03735901, source copy `cardio:ctgov-nct03735901-2024-10-15`, retrieved 2026-10-26)
- Countries: Switzerland (ClinicalTrials.gov record NCT03735901, source copy `cardio:ctgov-nct03735901-2024-10-15`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03735901-2024-10-15`, retrieved 2026-10-26)

## The registry's words

- Brief title: Enhancement of Stroke Rehabilitation With Levodopa
- Acronym: ESTREL
- Condition: Acute Stroke
- Condition: Stroke Rehabilitation
- Intervention (Drug): IMP Levodopa 100mg/Carbidopa 25mg
- Intervention (Drug): Matching placebo
- Lead sponsor: University Hospital, Basel, Switzerland
- Lead sponsor class: OTHER
- Collaborator: Swiss National Science Foundation
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: University Hospital, Basel, Switzerland (`cardio:org-university-hospital-basel-switzerland`)
- Registry lists this organization as a collaborator: Swiss National Science Foundation (`cardio:org-swiss-national-science-foundation`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Levodopa Added to Stroke Rehabilitation: The ESTREL Randomized Clinical Trial (`cardio:pubmed-40982270`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: The impact of levodopa on post-stroke depression: the ESTREL-depression-study (`cardio:pubmed-41701756`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Time course of motor recovery after stroke with and without levodopa: a post hoc 6-month longitudinal analysis of the ESTREL trial (`cardio:pubmed-42525438`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 5da35a4178a13fca07a523e51f1b4449cbaf71cbdda0bd8a8c1a1efc935ba8ea
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
